An expert group at the European Medicines Agency will meet Thursday to decide whether the one-dose coronavirus vaccine made by Johnson & Johnson should be authorized for use across the European Union. If the shot is given the green light, it would be the fourth licensed vaccine for the coronavirus disease in the 27-country bloc. The Amsterdam-based EU medicines regulator has already approved vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca — but all of those vaccines require two doses. Health experts hope having another authorized shot might speed the slow pace of immunization across Europe, which has been struggling to get enough supplies and vaccinate the vulnerable.

Source: The Standard March 10, 2021 11:12 UTC